Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 192M
21.75x4.2x-2.54x6.73x14.72x17.08x1.46% 57.82B
32.16x5.94x0.79x8.12x25.19x25.74x0.06% 53.71B
-43.06x55.78x0.71x13.69x-40.15x-43.14x-.--% 23.8B
-18.33x1.12x2.76x4.37x-7.66x-6.46x-.--% 23.26B
25.89x2.53x1.89x5.11x13.48x16.12x-.--% 20.7B
24.77x2.82x-1.17x4.84x15.78x17.76x-.--% 17.81B
50.68x13x0.45x20.65x53.17x48.78x0.07% 16.9B
-560.54x21.76x11.37x39.3x-4381.59x-430.15x-.--% 16.36B
17.45x4.96x1.21x5.07x11.8x13.01x-.--% 13.96B
-77.82x28.22x1.73x8.13x-72.9x-58.39x-.--% 12.69B
3507.04x8.56x-34.36x15.12x92.27x316.53x-.--% 12.16B
-13.18x155.18x0.64x3436.15x-15.98x-13.04x-.--% 11.7B
-12.89x-87.54x6.39x95.09x-14.63x-14.25x-.--% 11.22B
-22.33x23.36x-0x21.02x-26.4x-21.01x-.--% 10.12B
12.34x6.07x0.03x8.9x12.88x15.11x-.--% 9.7B
-33.21x9.13x-0.6x - -30.77x-29.77x-.--% 8.98B
-17.78x8.84x3.8x114.05x-15.95x-14.5x - 8.85B
21.33x5.79x1.02x - - - 0.37% 8.34B
-6.66x - -0.13x - -6.83x-6.28x-.--% 8.19B
Average 153.03x 14.99x -0.32x 237.90x -242.98x -9.27x 0.11% 17.32B
Weighted average by Cap. 102.15x 13.20x -0.22x 141.42x -206.42x -5.63x 0.27%
Bio Therapeutic Drugs